9EQ-30624-98558
3 vaccinations
4 coded responses
15 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 535 / WI
- Registered
- 2021-10-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-15
Dose 1 — Moderna
-
2021-03-15
Dose 2 — Moderna
-
2021-10-29
Dose 3 — Pfizer-BioNTech
-
2021-10-30
Registered in v-safe
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-31
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: swollen lymph node in armpit of injection. arm is fineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: my armpit lymph node is still tender, but swelling is reducedMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Breakthrough COVID-19, COVID-19, Fatigue, Headache, Memory impairment, Migraine, Parosmia, Taste disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: covid breakthrough case and after 12 days I had migraines and daily headaches appear until yesterday. Also extra fatigue and moments of forgetfulness like when I had covid, also disappearing. I had enhanced taste and smell which has stayedMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Survey response — 6 months, dose 3MedDRA: COVID-19, Cluster headache, Hypoaesthesia, Neurological symptom, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Since having covid I have neurological symptoms on my right side. Numbness and tingling in my right hand and foot and occasionally arm/leg, recently also on left side, also cluster headaches. · Healthcare visit (other): appointment and follow up after 90 days to see if persisting. I am awaiting an appointment with Neurology.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-05-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-15 | Moderna | No |
| 2 | 2021-03-15 | Moderna | No |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): swollen lymph node in armpit of injection. arm is fine
Systemic reaction (other): my armpit lymph node is still tender, but swelling is reduced
Release 11 — 3 months, dose 3
Symptoms: covid breakthrough case and after 12 days I had migraines and daily headaches appear until yesterday. Also extra fatigue and moments of forgetfulness like when I had covid, also disappearing. I had enhanced taste and smell which has stayed
Release 11 — 6 months, dose 3
Symptoms: Since having covid I have neurological symptoms on my right side. Numbness and tingling in my right hand and foot and occasionally arm/leg, recently also on left side, also cluster headaches.
Healthcare visit (other): appointment and follow up after 90 days to see if persisting. I am awaiting an appointment with Neurology.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Cluster headache | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Neurological symptom | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release